Hacker News new | past | comments | ask | show | jobs | submit login

Well, Purdue's hands are tied in terms other dosing. They have state the 12 hours that's in the FDA approved label.

In terms of price, they were quite expensive, but I've never met an insurer who is happy with the price of a drug.




Their hands were certainly not tied. They could have simply withdrawn the drug or petitioned the FDA to revise the dosing schedule.

They didn't do that because they decided money was more important than hundreds of thousands of peoples lives.


That seems like a big stretch.

The FDA approves their dosing schedule after a careful examination of the clinical trial data. They are required to stick to 12 hour dosing. Based on anecdotal reports, you're suggesting they withdrawal the drug from the market?




Guidelines | FAQ | Support | API | Security | Lists | Bookmarklet | Legal | Apply to YC | Contact

Search: